BEYFORTUS 50 mg, solution for injection in a pre-filled syringe syringe, 0.5 ml + 2 needles
Active ingredients: NIRSÉVIMAB
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.5 ml + 2 needlesintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BEYFORTUS 50 mg, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 seringue préremplie en verre de 0,5 mL + 2 aiguilles
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
62438151CIP73026859CIP133400930268599Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NIRSÉVIMABsolution | 50 mg · une seringue préremplie de 0,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.